Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.
about
Use of Reporter Genes in the Generation of Vaccinia Virus-Derived VectorsAsymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein BViral sequestration of antigen subverts cross presentation to CD8(+) T cells.Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.Vaccine-induced serum immunoglobin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells.Herpes simplex viruses: is a vaccine tenable?Vaccinia virus vectors: new strategies for producing recombinant vaccines.Immune responses to replication-defective HSV-1 type vectors within the CNS: implications for gene therapy.Duck enteritis virus glycoprotein D and B DNA vaccines induce immune responses and immunoprotection in Pekin ducksDiscovery of potential diagnostic and vaccine antigens in herpes simplex virus 1 and 2 by proteome-wide antibody profiling.Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1Glycoprotein D adjuvant herpes simplex virus vaccine.Prospects for developing an effective vaccine against ocular herpes simplex virus infection.Long-lived cytotoxic T lymphocyte memory in mucosal tissues after mucosal but not systemic immunizationA locus on mouse chromosome 6 that determines resistance to herpes simplex virus also influences reactivation, while an unlinked locus augments resistance of female mice.Induction of primary, antiviral cytotoxic, and proliferative responses with antigens administered via dendritic cellsReplication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.Expression of the Marek's disease virus (MDV) homolog of glycoprotein B of herpes simplex virus by a recombinant baculovirus and its identification as the B antigen (gp100, gp60, gp49) of MDV.Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.Increased expression in vivo and in vitro of foreign genes directed by A-type inclusion body hybrid promoters in recombinant vaccinia viruses.Protection from herpes simplex virus type 1 lethal and latent infections by secreted recombinant glycoprotein B constitutively expressed in human cells with a BK virus episomal vector.Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.Avian infectious laryngotracheitis: virus-host interactions in relation to prospects for eradication.Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodiesAnalysis of the cytolytic T-lymphocyte response to herpes simplex virus type 1 glycoprotein B during primary and secondary infection.Protection against Marek's disease by a fowlpox virus recombinant expressing the glycoprotein B of Marek's disease virus.Coexpression by vaccinia virus recombinants of equine herpesvirus 1 glycoproteins gp13 and gp14 results in potentiated immunity.Protection studies against Marek's disease using baculovirus-expressed glycoproteins B and C of Marek's disease virus type 1.Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D.
P2860
Q26746915-F39A8ADA-AAF3-479B-995B-D2709E2CC3B7Q30847945-94EDF4FE-8953-468B-B5AC-0815E4F7EB99Q33455511-1664BA8B-93C2-4455-8993-0F181F1F4B86Q33785966-2CC80821-B5B9-45C7-8B95-DDD36C2C06E5Q33836053-F0E6D2E0-DDC4-48D1-9C2F-E3FA3222A07DQ34139375-A5655D4A-3533-4312-AEF1-DD4AFB6E9F9DQ34211635-D835E91F-6CFA-48EF-8F50-B493BFA2049FQ35131218-6513BA5A-B493-4582-BE79-9AD557A9682FQ35149059-FEB0FC64-580D-45C5-9AAC-BD4337F41C6EQ35868054-7A4E20DC-F3C1-49D8-93E8-8E4AE1017089Q35882585-194344A9-7A73-4AD0-B578-B7FC50664E66Q36284536-413CDEE8-FB83-4BA0-97F0-9C77DF03353BQ36311038-BB981DA3-0E88-4D81-96F0-77FDF92B6635Q36367536-248469CE-11E0-4E46-922E-6ADBCB5A2EA1Q36540912-0ACEE1A9-607D-4726-A7EA-175E556689E3Q36650065-D3A5914F-0DF4-4648-8DCA-2DBDDFC4DF06Q36686845-EDDFDD72-BF2B-4A8B-BA56-B23FFF2E6CA9Q36696633-5535519B-4342-4285-9433-78FC845B7DA3Q36793186-DA09C6EC-F7D8-435F-BE7B-898DB32F26D3Q36798603-997A2C1D-D72C-40A2-8700-3B403DEBE9E2Q36799854-B2FBF12C-EC28-4E0A-B462-1CB3E6BA8BC9Q36830970-365EE0E9-A77E-47FF-8C27-D165350CB43BQ37223486-62A98DD8-E4A8-42F6-94BC-0DD329C21167Q37252171-E5E17A45-2D06-4439-A7F7-68229C23213EQ39874308-24A17555-A08C-4FE8-AA16-85C3EE2753ADQ40042703-8EF096CA-06F5-4C0D-BF1B-762869278F52Q40064381-F25A6BB9-3B98-447D-A1CE-6005E7AACB3CQ40108953-A48293A7-A7CC-4A9F-B23B-A871EAD12445Q45392751-367E9A61-BAA4-42DE-98A0-BE1C9727CB3CQ45751762-D4D06046-4A15-48FF-8EDE-D54D1883B25C
P2860
Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection.
description
1987 nî lūn-bûn
@nan
1987 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@ast
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@en
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@nl
type
label
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@ast
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@en
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@nl
prefLabel
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@ast
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@en
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@nl
P2093
P2860
P356
P1476
Expression of herpes simplex v ...... pes simplex virus 1 infection.
@en
P2093
A L Notkins
D E Willey
E M Cantin
H Openshaw
J L Baldick
P2860
P304
P356
10.1073/PNAS.84.16.5908
P407
P577
1987-08-01T00:00:00Z